Accelerating Precision Medicine Through Illumina’s Global Ecosystem
- Expand global patient access through Illumina’s commercial and regulatory expertise
- Enable custom CDx development through Illumina’s network of assay development partners
- Utilise TruSight Oncology Comprehensive to drive biomarker identification, clinical validation, and oncology patient access throughout the world